What could probiotic do for us?

Food Science and Human Wellness

Volumn 3, Issue 2, 2014, Pages 47-50

  Lee, Yuan Kun ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85068981223     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2014.06.001     Document Type: Article

References (48)

1. Rhodes, J., The role of Escherichia coli in inflammatory bowel disease. Gut 56 (2007), 610–612.
2. Willing, B., Halfvarson, J., Dicksved, J., et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15 (2009), 653–660.
3. Zella, G.C., Hait, E.J., Glavan, T., et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel Dis. 17 (2011), 1092–1100.
4. FAO/WHO, Joint Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, October 2001.
5. Lawley, T.D., Walker, A.W., Intestinal colonization resistance. Immunology 138:1 (2013), 1–11.
6. Salminen, S., Gibson, G.R., McCartney, A.L., Isolauri, E., Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53 (2004), 1388–1389.
7. Dominguez-Belloa, M.G., Costellob, E.K., Contrerasc, M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107:26 (2010), 11971–11975.
8. Kolokotroni, O., Middleton, N., Gavatha, M., et al. Asthma and atopy in children born by caesarean section: effect modification by family history of allergies – a population based cross-sectional study. BMC Pediatr. 12 (2012), 179–188.
9. Bager, P., Wohlfahrt, J., Westergaard, T., Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin. Exp. Allergy 38:4 (2008), 634–642.
10. Lee, Y.K., Puong, K.Y., Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br. J. Nutr. 88:Suppl. 1 (2002), S101–S108.
11. de Filippo, C., Cavalieria, D., Paolab, M.D., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 14691–14696.
12. Zhang, J.C., Guo, Z., Lim, A.A.Q., et al. Mongolians core gut microbiota and its correlation with seasonal dietary changes. Sci. Rep., 4, 2014, 5001, 10.1038/srep05001.
13. Gotz, V., Romankiewicz, J.A., Moss, J., Murray, H.W., Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am. J. Hosp. Pharm. 36 (1979), 754–757.
14. Lee, Y.K., Lim, C.Y., Teng, W.L., et al. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl. Environ. Microbiol. 66 (2000), 3692–3697.
15. Maassen, C.B., van Holten-Neelen, C., Balk, F., et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:23 (2000), 2613–2623.
16. Kalliomäki, M., Salminen, S., Arvilommi, H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:9262 (2001), 1076–1079.
17. Kalliomäki, M., Salminen, S., Poussa, T., et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:9372 (2003), 1869–1871.
18. Kalliomäki, M., Salminen, S., Poussa, T., Isolauri, E., Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119:4 (2007), 1019–1021.
19. Gionchetti, P., Rizzello, F., Venturi, A., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:2 (2000), 305–309.
20. Bibiloni, R., Fedorak, R.N., Tannock, G.W., et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100:7 (2005), 1539–1546.
21. Koebnick, C., Wagner, I., Leitzmann, P., et al. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can. J. Gastroenterol. 17:11 (2003), 655–659.
22. Nobaek, S., Johansson, M.L., Molin, G., et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 95:5 (2000), 1231–1238.
23. O'Sullivan, M.A., O'Morain, C.A., Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig. Liver Dis. 32:4 (2000), 294–301.
24. de Vrese, M., Winkler, P., Rautenberg, P., et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:44–46 (2006), 6670–6674.
25. de Vrese, M., Winkler, P., Rautenberg, P., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin. Nutr. 24:4 (2005), 481–491.
26. Homayouni, A., Bastani, P., Ziyadi, S., et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J. Low. Genit. Tract Dis. 18:1 (2014), 79–86.
27. Grin, P.M., Kowalewska, P.M., Alhazzan, W., Fox-Robichaud, A.E., Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can. J. Urol. 20:1 (2013), 6607–6614.
28. Vitali, B., Cruciani, F., Baldassarre, M.E., et al. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 12 (2012), 236–250.
29. Eichholzer, M., Gutzwiller, F., Dietary nitrates, nitrites, and N-nitroso compounds and cancer risk: a review of the epidemiologic evidence. Nutr. Rev. 56:4 (1998), 95–105.
30. Giovannucci, E., Rimm, E.B., Stampfer, M.J., et al. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 54 (1994), 2390–2397.
31. Chung, K.T., The etiology of bladder cancer and its prevention. J. Cancer Sci. Ther. 5:10 (2013), 346–361.
32. Blaut, M., Clavel, T., Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr. 137:3 (2007), 751S–755S.
33. Chadwick, R.W., George, S.E., Claxton, L.D., Role of gastrointestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens. Drug Metab. Rev. 24 (1992), 425–492.
34. Robertson, A.M., Roles of endogenous substances and bacteria in colorectal cancer. Mutat. Res. 290 (1993), 71–78.
35. Nanno, M., Kato, I., Kobayashi, T., Shida, K., Biological effects of probiotics: what impact does Lactobacillus casei Shirota have on us?. Int. J. Immunopathol. Pharmacol. 24:1 Suppl. (2011), 45S–50S.
36. Naito, S., Koga, H., Yamaguchi, A., et al. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer. J. Urol. 179 (2008), 485–490.
37. Ohashi, Y., Nakai, S., Tsukamoto, T., et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol. Int. 68 (2002), 273–280.
38. Cani, P.D., Amar, J., Iglesias, M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:7 (2007), 1761–1772.
39. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27:1 (2013), 73–83.
40. Everard, A., Belzer, C., Geurts, L., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110:22 (2013), 9066–9071.
41. Cani, P.D., Bibiloni, R., Knauf, C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:6 (2008), 1470–1481.
42. Desbonnet, L., Garrett, L., Clarke, G., et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
43. Singh, P.K., Chopra, K., Kuhad, A., Kaur, I.P., Role of Lactobacillus acidophilus loaded floating beads in chronic fatigue syndrome: behavioural and biochemical evidences. Neurogastroenterol. Motil. 24:4 (2012), 366–376.
44. Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 61 (2007), 355–361.
45. Rao, A.V., Bested, A.C., Beaulne, T.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 1 (2009), 6–12.
46. Gareau, M.G., Wine, E., Rodrigues, D.M., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60 (2011), 307–317.
47. Collins, M.S., Surette, M., Bercik, P., The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10 (2012), 735–742.
48. Sanger, J.G., Lee, K., Hormones of the gut–brain axis as targets for the treatment of upper gastrointestinal disorders. Nat. Rev. Drug Discov. 7 (2008), 241–254.